Highly sensitive liquid biopsy screening test, engineered to analyse venous blood samples efficiently and non-invasively. This screening test targets colon, lung and breast tumours, which are among the most prevalent malignancies globally. Symptoms are frequently ambiguous and may be readily disregarded. An increasing percentage of malignancies are treatable; nonetheless, early diagnosis is crucial since it enhances the survival rate.
This screening test is available for purchase only in conjunction with at least one additional liquid biopsy test.
The test can be performed anytime and professional societies have recommendations according to the cancer type. An early detection enables very efficient treatment and recovery. The later the disease is detected, the more complicated is the treatment.
This test can save you time, while each type of cancer may regards different examination(s) like biopsy, x-ray, Computer tomography atd.. Regular screening is important to recognize it in time!
You are 40+
You experienced blood in your stool
You have got CRC in your family history
You loose weight from unknown reasons
You have got inflammatory bowel disease
You have persistent pain or cramps in abdomen
- Invasive Breast Cancer
- Invasive lobular Breast Cancer
- Lobular carcinoma in situ
- Ductal carcinoma in situ
- Triple negative breast cancer
- Paget's disease
After you purchased the test, you get the AveGene ct/cfDNA liquid biopsy somatic & germinal mutations sample collection & transport kit. Arrange the blood draw according to the enclosed instructions.
Send sample to nearest AveGene collection center or to central AveGene laboratory.
Receive your results in the form of an encrypted PDF report. Request an online consultation if needed.
About Breast Cancer
Breast cancer is characterized by the uncontrolled proliferation of abnormal cells in the breast tissue, primarily originating in the milk ducts (ductal carcinoma) or the lobules (lobular carcinoma). The disease can be classified into in situ forms, which are non-invasive and typically not life-threatening, and invasive forms that can penetrate surrounding tissues and metastasize to regional lymph nodes and distant organs. The transition from localized growth to invasive cancer is marked by genetic and epigenetic alterations that enable tumor cells to evade normal regulatory mechanisms, promoting invasion and metastasis. Treatment modalities are personalized based on the tumor's molecular profile, stage, and the patient's overall health, often combining surgical intervention, radiation therapy, and systemic treatments such as chemotherapy and targeted therapies.
There is no danger to any of your private data on AveGene.
We make sure that even the internal testing is done in secret. In a way, we don't even need to know the patient's name. The molecular state of the blood or plasma sample sent to us is only interpreted with an anonymous sample ID. The person who has the activation card information is the only one who can see the results.
